BIOGEN INC. (BIIB) Stock buybacks 2016–2024
BIOGEN INC. (BIIB) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2024 · since FY2016: $1.0B → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $750.0M | -58.3% |
| FY2021 | $1.8B | -73.1% |
| FY2020 | $6.7B | +13.8% |
| FY2019 | $5.9B | +34.8% |
| FY2018 | $4.4B | +218.8% |
| FY2017 | $1.4B | +36.5% |
| FY2016 | $1.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Net marginBIIB Gross profitBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →